Surgalign Holdings, Inc., (NASDAQ:SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is proud to announce today, the release of HOLO™ AI
Everi Holdings Inc. ("Everi" or the "Company"), announced that it has terminated its stock repurchase program effective May 2, 2024. On May 3, 2023, the Company's Board of Directors approved the stock repurchase program